Dabrico
Dabrico supplies AI-powered automated visual inspection equipment for pharmaceutical injectable products, anchored by the DAI-50 system using unsupervised machine learning. Founded in 1979, the company serves CMOs, drug manufacturers, and 503B facilities globally with capital equipment, validation services, and technical support.
- Company typePrivate
- Founded1980
- HeadquartersBourbonnais, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Dabrico does
Dabrico is a US-based, privately held supplier of visual inspection equipment for the pharmaceutical industry, founded in 1979 and headquartered in Bourbonnais, Illinois. The company designs, manufactures, and services capital equipment used to inspect injectable drug products — vials, syringes, and ampoules ranging from 1 mL to 1,000 mL — for particulate contamination, cosmetic defects, container closure integrity, and fill-level anomalies. Its product portfolio spans manual inspection stations, semi-automated systems, and the flagship DAI-50 fully automated visual inspection machine, complemented by auxiliary equipment including pharmaceutical conveyors, accumulation tables, and syringe stopper insertion tools, plus IQ/OQ/PQ qualification and inspector training services.
The DAI-50 is the core technology differentiator and is powered by Boon Logic's AVIS unsupervised machine learning platform. Unlike rule-based machine vision or supervised neural networks that require large labeled defect libraries, AVIS trains on approximately 500 pre-inspected compliant units to model normal product variation and flags any unit falling outside that pattern as an anomaly — enabling detection of previously unseen defect types with 99% detection accuracy and a <1% false eject rate. Recipe training takes roughly 60 minutes, and GMP qualification is achievable in under six weeks. The system inspects up to 90 units per minute and is positioned for difficult-to-inspect formulations (lyophilized products, suspensions, molded glass vials, opaque or bubble-prone liquids) where traditional AVI systems structurally fail.
Dabrico operates a direct enterprise field-sales motion targeting quality directors, operations managers, and regulatory affairs professionals at pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and 503B outsourcing facilities. Revenue is generated through capital equipment sales ($1M–$4M+ per system based on industry benchmarks), bundled or standalone qualification/validation services, and recurring service contracts covering preventive maintenance, software updates, and recipe revalidation. The company claims a global customer base and supports sales with an extensive content-marketing program covering USP, FDA, and EU GMP Annex 1 regulatory frameworks. The company is privately held with no disclosed funding history, headcount, or financial statements.
Dabrico firmographics
Firmographics- Name
- Dabrico
- Legal name
- Dabrico
- Website
- https://dabrico.com
- Company type
- Private
- Founded year
- 1980
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Dabrico supplies AI-powered automated visual inspection equipment for pharmaceutical injectable products, anchored by the DAI-50 system using unsupervised machine learning. Founded in 1979, the company serves CMOs, drug manufacturers, and 503B facilities globally with capital equipment, validation services, and technical support.
- Ownership category
- akta.pro rank
Where Dabrico is headquartered
LocationHeadquarters
- HQ city
- Bourbonnais
- HQ country
- United States
- HQ region
- North America
Markets served
Dabrico business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Automated Visual Inspection Hardware Systems: Sale of DAI-50 and related automated visual inspection machines. Capital equipment sale model with significant upfront investment ($1M–$4M+ range based on industry benchmarks for comparable AVI systems). Equipment includes the inspection machine hardware, cameras, lighting, material handling, and control systems. Revenue recognized upon equipment delivery, installation, and qualification.
- Qualification and Validation Services: IQ/OQ/PQ validation services, on-site feasibility studies, recipe development support, and installation/operational qualification. Typically bundled with hardware sale or offered as standalone service for customers evaluating the platform. Helps customers reach GMP readiness — under 6 weeks for the DAI-50 vs. months for traditional AVI systems.
- Service and Technical Support: Ongoing service contracts and technical support for installed DAI-50 systems. Includes preventive maintenance, software updates, recipe revalidation support, and remote/in-field technical assistance.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Dabrico product offering
Product offeringCore offering
Dabrico sells capital equipment and supporting services for 100% visual inspection of pharmaceutical injectable products. Its core product, the DAI-50, is an AI-powered automated visual inspection machine for vials, syringes, and ampoules (1–1,000 mL) at up to 90 units/minute, paired with semi-automated and manual inspection stations, auxiliary material-handling equipment (conveyors, accumulation tables, syringe stopper insertion presses), and IQ/OQ/PQ qualification and training services supporting GMP readiness.
Product overview
Dabrico offers a portfolio of visual inspection solutions for the pharmaceutical industry, ranging from fully automated AI-powered systems to manual inspection methods. The core product is the DAI-50, the world's first automated visual inspection machine built specifically for difficult-to-inspect injectable products, powered by Boon Logic's AVIS unsupervised machine learning platform. This is complemented by semi-automated and manual visual inspection systems, plus auxiliary equipment including pharmaceutical conveyors, accumulation tables, and syringe stopper insertion tools. The company also provides qualification and training services to support GMP compliance. The product line addresses various container formats (vials, syringes, ampoules) and product types (freeze-dried, milky, bubble-prone, suspensions, water-like solutions).
Differentiator
Problem solved
Functional benefit
Products and services
- DAI-50 Automated Visual Inspection Machine The world's first fully automated visual inspection machine built for difficult-to-inspect injectable products. Powered by Boon Logic's AVIS unsupervised machine learning platform, it handles vials, syringes, and ampoules (1 mL to 1,000 mL) at up to 90 units per minute and delivers 99% detection accuracy for particulate and cosmetic defects. Recipe training takes 60 minutes using ~500 compliant units; GMP qualification achieved in under 6 weeks.
- Automated Visual Inspection Systems AI-based automated visual inspection systems using machine vision and artificial intelligence to inspect pharmaceutical containers at high speed with no human in the loop for pass/reject decisions. Combine high-resolution cameras, controlled lighting, and AI-driven detection to evaluate products for particulate contamination, cosmetic defects, and container closure integrity.
- Semi-Automated Visual Inspection Stations Inspection systems that combine machine assistance with human judgment. Equipment handles repetitive tasks such as rotating containers and positioning them under standardized lighting, while an operator evaluates the product and makes the final accept-or-reject decision. Operates at 10 to 30 units per minute.
- Manual Visual Inspection Stations Traditional human-based visual inspection using trained operators who examine pharmaceutical containers by hand under controlled lighting conditions against black and white backgrounds. Typically achieves 5 to 10 units per minute throughput.
- Syringe Stopper Insertion Tool and Press Equipment for individual stopper insertion in syringe manufacturing, enabling precise placement of stoppers in pharmaceutical syringes. Used alongside inspection systems.
- Pharmaceutical Conveyors Conveyor systems designed for pharmaceutical manufacturing environments to transport containers through production lines, integrated with inspection systems.
- Accumulation Tables Auxiliary equipment for managing container flow during pharmaceutical manufacturing, providing accumulation capacity between production stages.
- Pharmaceutical Qualification and Training Services Pharma support services including IQ, OQ, and PQ validation workflows, Knapp test support, inspector training programs, and qualification documentation to help manufacturers meet GMP requirements for visual inspection systems.
Quantifiable outcome
- 99% detection accuracy for particulate and cosmetic defects
- +9 more outcomes
Companies that use Dabrico
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Dabrico technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
Dabrico partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Boon LogiccoreDabrico's DAI-50 automated visual inspection machine is powered by Boon Logic's AVIS (Automated Vision Inspection System) platform. AVIS provides the unsupervised machine learning technology that enables the DAI-50 to learn normal product variation from compliant units without requiring labeled defect libraries. This is a foundational technology partnership where Boon Logic's AI software is integrated into Dabrico's hardware platform to deliver AI-powered pharmaceutical visual inspection.
Scale indicators10 records
Recent moves5 records
Expansion highlights5 records
Dabrico competitors and assessment
Company assessmentDirect peers
- ACG Inspection: ACG Inspection (part of ACG Group) provides automated visual inspection and packaging solutions for pharmaceutical solid dosage, injectable, and other formats. It competes with Dabrico in the global pharmaceutical inspection equipment market.
- Stevanato Group: Stevanato's MAVIS automated visual inspection machine is a direct competitor to Dabrico's DAI-50 in the sterile injectable inspection market. Stevanato uniquely combines glass container manufacturing with inspection equipment, offering vertically integrated solutions to pharma manufacturers.
- Syntegon (formerly Bosch Packaging Technology): Syntegon's AIM 9 automated inspection machine is a direct competitor to the DAI-50 in sterile injectable inspection. As a broad packaging equipment incumbent, Syntegon also offers integrated fill-finish lines that bundle inspection with other equipment.
- Brevetti CEA: Brevetti's K32S and related AVI systems compete directly with Dabrico in pharmaceutical visual inspection for vials, syringes, and ampoules. The K32S was specifically named as a competitor in the Top 8 AVI guide ranking.
- Antares Vision: Antares Vision provides automated visual inspection and serialization/track-and-trace systems for pharmaceuticals and medical devices. Its AI-based inspection solutions overlap with Dabrico's DAI-50 offering for injectable products and parenteral inspection.
- OPTEL Group: OPTEL provides vision inspection solutions for pharmaceutical manufacturing, including AI-based inspection of packaging lines. Its offerings overlap with Dabrico's inspection technology in pharma quality control applications.
- Körber (Seidenader): Körber's Seidenader business is a leading global supplier of automated visual inspection equipment for pharmaceutical injectable products. It competes directly with Dabrico's DAI-50 across vial, syringe, and ampoule inspection, and was ranked just behind Dabrico in the referenced Top 8 AVI guide.
- Bausch+Ströbel: Bausch+Ströbel manufactures pharmaceutical filling and packaging equipment with integrated visual inspection capabilities. It competes with Dabrico in the aseptic fill-finish segment for vials, syringes, and ampoules sold to pharmaceutical manufacturers globally.
Regional players
- Jekson Vision: Jekson Vision provides machine vision systems for pharmaceutical packaging and inspection, with strong presence in Asia and global expansion. Its visual inspection technology overlaps with Dabrico's offerings for injectable and parenteral products.
Emerging players
- Boon Logic: Boon Logic is the AI/ML partner whose AVIS unsupervised learning platform powers the DAI-50. While not a direct competitor in inspection hardware, Boon Logic is an enabling technology vendor whose roadmap directly shapes Dabrico's product capability.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Dabrico social profiles
Digital presenceDabrico financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dabrico leadership team
Management profileNumber of profiles
Dabrico funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dabrico M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dabrico
What does Dabrico do?
Dabrico sells capital equipment and supporting services for 100% visual inspection of pharmaceutical injectable products. Its core product, the DAI-50, is an AI-powered automated visual inspection machine for vials, syringes, and ampoules (1–1,000 mL) at up to 90 units/minute, paired with semi-automated and manual inspection stations, auxiliary material-handling equipment (conveyors, accumulation tables, syringe stopper insertion presses), and IQ/OQ/PQ qualification and training services supporting GMP readiness.
Is Dabrico a public or private company?
Dabrico is a private company. It is classified as unknown and is currently operating.
When was Dabrico founded?
Dabrico was founded in 1980. It employs 11 to 50 people.
Where is Dabrico based?
Dabrico is headquartered in Bourbonnais, United States, in the North America region.
How does Dabrico make money?
Three revenue lines are on record. Automated Visual Inspection Hardware Systems are the primary driver. The others are qualification and Validation Services and service and Technical Support.
Who are Dabrico's main competitors?
Direct peers on record are ACG Inspection, Stevanato Group, Syntegon (formerly Bosch Packaging Technology), Brevetti CEA, Antares Vision, OPTEL Group, Körber (Seidenader) and Bausch+Ströbel. Jekson Vision is listed as a regional player. Boon Logic is listed as an emerging player.
Does Dabrico have an API?
No public API is recorded for Dabrico.